Earnings Feed
Start Free
Home/Insiders/MacKenzie Lloyd
ML
SEC Insider//CIK 0001600164

MacKenzie Lloyd

CIK 00016001641 companyVANCOUVER, A1
SEC Profile

Transactions

13

Companies

1

Filings

7

CIK

0001600164

Recent Transactions

13 trades
  • Award
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2018-08-07+145,000→ 145,000 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Common Stock

    2018-03-15$10.56/sh+1,302→ 1,302 total
  • Sale
    Neurogene Inc.$NGNE

    Common Stock

    2018-03-15$14.63/sh−1,302→ 0 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2018-03-15−1,302→ 0 total
  • Award
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2018-03-09+75,000→ 75,000 total
  • Award
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2017-03-08+50,000→ 50,000 total
  • Award
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2016-03-10+35,000→ 35,000 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2015-08-12+7,812→ 0 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Common Stock

    2015-08-12$5.76/sh+28,075→ 35,887 total
  • Sale
    Neurogene Inc.$NGNE

    Common Stock

    2015-08-12$18.67/sh−35,887→ 0 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2015-08-12+28,075→ 1,872 total
  • Exercise/Conversion
    Neurogene Inc.$NGNE

    Common Stock

    2015-08-12$5.76/sh+7,812→ 7,812 total
  • Award
    Neurogene Inc.$NGNE

    Stock Option (Right to Buy)

    2015-03-12+25,000→ 25,000 total

Companies

1

Recent Filings

7

Address

C/O AQUINOX PHARMACEUTICALS, INC. 450 - 887 GREAT NORTHERN WAY

VANCOUVER, A1, V5T 4T5

View on SEC.gov